Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 13, 2020

SELL
$85.91 - $100.83 $182,730 - $214,465
-2,127 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $156,057 - $208,828
2,127 New
2,127 $209,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Windward Capital Management CO Portfolio

Follow Windward Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windward Capital Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Windward Capital Management CO with notifications on news.